{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:05:32Z","timestamp":1789718732796,"version":"4.0.1"},"reference-count":6,"publisher":"SAGE Publications","issue":"11","license":[{"start":{"date-parts":[[2000,11,1]],"date-time":"2000-11-01T00:00:00Z","timestamp":973036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Foot Ankle Int."],"published-print":{"date-parts":[[2000,11]]},"abstract":"<jats:p>Treatment of Charcot foot osteoarthropathy has emerged as a major component of the American Orthopaedic Foot and Ankle Society (AOFAS) Diabetes 2000 Initiative. A two-part survey described treatment patterns and current footwear use of patients with Charcot osteoarthropathy of the foot and ankle. In the first part, 94 consecutive patients with a history of Charcot foot and ankle presenting for care were questioned on their foot-specific treatment and current footwear use. A history of diabetic foot ulcer was given by 39 (41%) patients, and an infection had been present in a foot of 20 (21%) patients. The initial treatment of the Charcot foot and ankle had been a total contact cast in 46 (49%) patients, and a pre-fabricated walking boot in 19 (20%). Charcot related surgery had consisted of 76 procedures in 46 (49%) patients. Sixty-three (67%) patients were currently using accommodative footwear (depth-inlay shoes in 46 [49%], custom shoes in 10 [11%], and CROW in 7 [7%] patients), and 72 (77%) were currently using custom accommodative foot orthoses.<\/jats:p>\n                  <jats:p>The second part of this study consisted of a questionnaire completed by 37 orthopaedic surgeons (members of AOFAS) interested in forming a Charcot Study Group. They treated an average of 11.8 patients having Charcot foot or ankle per month. Thirty (81%) used the Semmes-Weinstein 5.07 monofilament as a screening tool for peripheral neuropathy. For treatment of Eichenholtz Stage I, 29 (78%) used a total contact cast and 15 (41%) allowed weightbearing; for Stage II, 30 (81%) physicians used a total contact cast and 18 (49%) allowed weightbearing.<\/jats:p>\n                  <jats:p>Although the literature contains uniform recommendations for immobilization and non-weightbearing as treatment for the initial phases of Charcot arthropathy, the results of this benchmarking study reveal that current treatment is varied.<\/jats:p>","DOI":"10.1177\/107110070002101105","type":"journal-article","created":{"date-parts":[[2017,2,14]],"date-time":"2017-02-14T03:48:27Z","timestamp":1487044107000},"page":"916-920","source":"Crossref","is-referenced-by-count":74,"title":["Current Practice Patterns in the Treatment of Charcot Foot"],"prefix":"10.1177","volume":"21","author":[{"given":"Michael S.","family":"Pinzur","sequence":"first","affiliation":[{"name":"Maywood, IL, Wichita, KS and New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Shields","sequence":"additional","affiliation":[{"name":"Maywood, IL, Wichita, KS and New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elly","family":"Trepman","sequence":"additional","affiliation":[{"name":"Maywood, IL, Wichita, KS and New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Dawson","sequence":"additional","affiliation":[{"name":"Maywood, IL, Wichita, KS and New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Evans","sequence":"additional","affiliation":[{"name":"Maywood, IL, Wichita, KS and New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2000,11,1]]},"reference":[{"key":"bibr1-107110070002101105","volume-title":"Charcot Joints","author":"Eichenholtz SN","year":"1966"},{"key":"bibr2-107110070002101105","unstructured":"2. National Diabetes Fact Sheet. United States Department of Health and Human Services. Washington, DC. November 1, 1998."},{"key":"bibr3-107110070002101105","doi-asserted-by":"publisher","DOI":"10.1177\/107110079301400403"},{"key":"bibr4-107110070002101105","doi-asserted-by":"publisher","DOI":"10.1177\/107110079902000905"},{"key":"bibr5-107110070002101105","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9610(98)00181-0"},{"key":"bibr6-107110070002101105","doi-asserted-by":"publisher","DOI":"10.1177\/107110079701800714"}],"container-title":["Foot &amp; Ankle International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/107110070002101105","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/107110070002101105","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/107110070002101105","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T21:19:40Z","timestamp":1777411180000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/107110070002101105"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,11]]},"references-count":6,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2000,11]]}},"alternative-id":["10.1177\/107110070002101105"],"URL":"https:\/\/doi.org\/10.1177\/107110070002101105","relation":{},"ISSN":["1071-1007","1944-7876"],"issn-type":[{"value":"1071-1007","type":"print"},{"value":"1944-7876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,11]]}}}